Watson Pharma Private Limited
Watson Pharma Private Limited Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20120088886 | PROCESSES FOR THE PREPARATION OF SEVELAMER CARBONATE - Processes for preparing Sevelamer Hydrochloride and Sevelamer Carbonate are described. | 04-12-2012 |
20110207949 | PROCESS FOR THE PREPARATION OF RAMELTEON - Disclosed herein is a process for resolving N-[2-(1,6,7,8-tetrahydro-2H-indeno [5,4-b] furan-8-yl)] ethylamine into its isomers using an optically active acid and a process for preparing ramelteon from the resolved isomer. | 08-25-2011 |
20110201804 | PROCESS FOR THE PREPARATION OF 1- ( 3-HYDROXYMETHYLPYRID-2 -YL ) -2 -PHENYL-4-METHYLPIPERAZINE AND MIRTAZAPINE - Disclosed herein is a process for the manufacture of mirtazapine and intermediates useful in preparing mirtazapine which includes the reduction of 1-(3-carboxypyridyl-2)-4-methyl-2-phenylpiperazine with an organoaluminum hydride. | 08-18-2011 |
20110144354 | Process for Preparation of Darifenacin and Intermediates Used in the Process - Disclosed herein is a process for the preparation of darifenacin and physiologically acceptable salts thereof. Also disclosed is a compound of formula X: wherein R is linear or branched C | 06-16-2011 |
20110065755 | STABLE R(+)-LANSOPRAZOLE AMINE SALT AND A PROCESS FOR PREPARING THE SAME - A stable R-(+)-lansoprazole alkylamine salt and a process for preparing the salt. | 03-17-2011 |
20100312010 | Process for the Preparation of (S)-Pregabalin - The present invention provides a process for resolving racemic pregabalin to S-pregabalin by using a chiral acid to form a pregabalin salt, purifying the salt to obtain a purified S- pregabalin salt then neutralizing the salt to obtain S-pregabalin having good chiral purity. | 12-09-2010 |
20100305318 | Process for the Manufacture of Anagrelide Hydrochloride Monohydrate - The present invention relates to a process for preparation of Anagrelide Hydrochloride Monohydrate. | 12-02-2010 |
20100280077 | Process for Preparation of Stable Amorphous R-Lansoprazole - A process for preparing stable amorphous R-(+)-lansoprazole comprising optically resolving racemic lansoprazole by the formation of host-guest inclusion complexes by selectively and reversibly including chiral guest molecules in the lansoprazole. | 11-04-2010 |